FDA Seeks Public Feedback On Regulatory Approach For Generative AI-Enabled Medical Devices

The FDA issued a discussion paper seeking public feedback on regulatory approaches for generative AI-enabled medical devices, proposing a risk-based framework and new premarket and postmarket evaluation models.

This Wire brief sits within Fusion42's coverage of Medtech, and 7 sources have reported it between 18 Aug 2026 and 24 Aug 2026.